A Mentor’s Advice for CFOs: How to Help Clients Navigate Their Way to Success
By

In my 45+ year career, I have been fortunate to be CFO at a number of technology and life science companies ranging in size from early stage to those with mature operations, private and public, including SmartRent, PARC, Vera Therapeutics, Amyris, Soleno Therapeutics, and Kyverna Therapeutics, among others. Over the…Read More

Read More
Advice for Life Sciences Companies Going Commercial for the First Time
By

Life sciences companies going commercial for the first time have the opportunity to create significant shareholder value – but the path to achieving this milestone will likely be volatile. The words that best sum up my advice to management teams and boards at life sciences companies that embark on the…Read More

Read More
Latest Insights: 2023 Healthcare, Technology and Consumer Trends
By

FLG Partners’ C-suite consulting and advisory practice supports a diverse continuum of industry sectors, from healthcare and life sciences to technology (SaaS and software to med tech and hardware) and consumer, from e-commerce to CPG. Our partners regularly attend many industry conferences and networking opportunities to stay abreast of the…Read More

Read More
Raising Capital in Life Sciences in 2022-2023: What Works?
By

Raising money in the capital markets for a biopharma or life sciences company over the last few years has been quite a roller coaster ride. Funding among U.S. biotech startups reached a record high of $77 billion in 2021 (Crunchbase), as investors were attracted to expanding opportunities in genetics, therapeutics…Read More

Read More

More Posts